Friday, 16 October 2026European Markets

PROACTIS SA Stock Bullish By 21% In The Last 10 Sessions

Loading stream...

recent financial news has shed light on the astonishing upsurge of french company proactis sa's (cac 40: proac.pa) shares. the shares recorded a noteworthy 21.95% growth over ten trading sessions - navigating from eur0.08 to eur0.10 after five consecutive losses. this surge reflects the spiraling investor confidence, as observed from the 0.15% increment in the cac 40 index, escalating to eur7,476.47.

proactis sa's services and performance

proactis sa, known for its source-to-pay software solutions, efficiently reversed into recuperation mode despite its share price remaining lower by 35.14% from its 52-week high of eur0.15. the company's core offering is an operational software platform that empowers businesses to manage their spending. the company also treads into the e-procurement arena by providing system administration support services, supplier onboarding assistance, invoice capture services, and spend management.

concerns for investors

nonetheless, investors are advised to be wary of the trailing twelve-month earnings per share (eps) figure that currently stands at eur-0.01. the negative eps and -3.88% return on equity figures symbolize a company operating in a loss-making position, consequently diminishing the shareholder's equity.

trading volume and market trends

the trading volume for proactis sa has reportedly seen a significant drop. the last reported volume was a mere 87, contrasting heavily with the average volume of 7746. this dip insinuates decreased engagement owed to investor apprehension around inconsistent profitability figures.

market volatility and investor sentiment

at present, proactis sa is trading slightly above its 50-day moving average of eur0.10 but still within the span of its 200-day moving average. such a trend translates to non-volatile market conditions from a broader perspective. however, some investors may be responding to general market sentiments while trading this stock. considering proactis sa's grim profitability numbers, it is advisable for investors to tread carefully and undertake more in-depth research before decision-making.

more news about proactis sa (proac.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com